Reference Product Identification

Reference Product Identification is a methodological process in pharmaceutical regulatory science that involves determining the appropriate comparator drug, known as the reference listed drug, for generic drug development and approval, distinguished by its role in establishing therapeutic equivalence and regulatory compliance.

23

Publications

672

Citations

146

Authors

42

Institutions

Publications per year

2017–2026

11

Publications

23

1–5 of 23

Authors

146

  1. SK
    Scott Kuhns

    Amgen (United States), United States

    2 publications · 45 citations

    2

    h-index

  2. RA
    Ronald A. Rader

    Advanced Bioscience Laboratories (United States), United States

    2 publications · 29 citations

    2

    h-index

  3. AH
    Alex Henderson

    University of Manchester, United Kingdom

    2 publications · 73 citations

    2

    h-index

  4. TE
    Thomas Eilers

    Technische Universität Braunschweig, Germany

    1 publications · 24 citations

    1

    h-index

  5. WG
    Wenyuan Gao

    Tianjin University, China

    1 publications · 39 citations

    1

    h-index

1–5 of 146

Venues

  1. BioDrugs

    3 publications · 95 citations

    3

    h-index

  2. mAbs

    2 publications · 188 citations

    2

    h-index

  3. Scientia Pharmaceutica

    1 publications · 14 citations

    1

    h-index

  4. PLoS ONE

    1 publications · 12 citations

    1

    h-index

  5. American Journal of Health-System Pharmacy

    AJHP · 1 publications · 17 citations

    1

    h-index

1–5